Logo image of EXFO

Exfo Inc (EXFO) Stock Fundamental Analysis

NASDAQ:EXFO - Nasdaq -

6.245  0 (-0.08%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EXFO. EXFO was compared to 48 industry peers in the Communications Equipment industry. EXFO may be in some trouble as it scores bad on both profitability and health. EXFO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EXFO had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -2.03%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.31%
PM (TTM) -2.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

EXFO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EXFO has an Altman-Z score of 3.35. This indicates that EXFO is financially healthy and has little risk of bankruptcy at the moment.
EXFO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.35
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

EXFO has a Current Ratio of 1.45. This is a normal value and indicates that EXFO is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 0.95 indicates that EXFO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.95

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 800.00% over the past year.
The Revenue has been growing slightly by 7.09% in the past year.
The Revenue has been growing slightly by 3.64% on average over the past years.
EPS 1Y (TTM)800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)7.09%
Revenue growth 3Y2.96%
Revenue growth 5Y3.64%
Sales Q2Q%9.82%

3.2 Future

The Earnings Per Share is expected to grow by 113.35% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXFO will show a quite strong growth in Revenue. The Revenue will grow by 11.24% on average per year.
EPS Next Y807%
EPS Next 2Y225.35%
EPS Next 3Y150.19%
EPS Next 5Y113.35%
Revenue Next Year11%
Revenue Next 2Y9.68%
Revenue Next 3Y9.14%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXFO Yearly Revenue VS EstimatesEXFO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
EXFO Yearly EPS VS EstimatesEXFO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 34.69, the valuation of EXFO can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.46, EXFO is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 36.37, the valuation of EXFO can be described as expensive.
EXFO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 34.69
Fwd PE 36.37
EXFO Price Earnings VS Forward Price EarningsEXFO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.86
EXFO Per share dataEXFO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

EXFO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXFO's earnings are expected to grow with 150.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y225.35%
EPS Next 3Y150.19%

More info and screens

0

5. Dividend

5.1 Amount

EXFO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Exfo Inc

NASDAQ:EXFO (8/27/2021, 8:06:28 PM)

6.245

0 (-0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-06 2021-10-06
Earnings (Next)01-11 2022-01-11
Inst Owners9.21%
Inst Owner Change14.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap358.75M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 34.69
Fwd PE 36.37
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB N/A
EV/EBITDA 22.86
EPS(TTM)0.18
EY2.88%
EPS(NY)0.17
Fwd EY2.75%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.94
BVpS3.24
TBVpSN/A
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.31%
PM (TTM) -2.18%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.95
Altman-Z 3.35
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y807%
EPS Next 2Y225.35%
EPS Next 3Y150.19%
EPS Next 5Y113.35%
Revenue 1Y (TTM)7.09%
Revenue growth 3Y2.96%
Revenue growth 5Y3.64%
Sales Q2Q%9.82%
Revenue Next Year11%
Revenue Next 2Y9.68%
Revenue Next 3Y9.14%
Revenue Next 5Y11.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A